Upcoming Webinars Archived Webinars Training Vitals Host A Webinar About Get Updates Contact

ICH E6 R2 - Guidance and road map of tools for navigating the regulatory landscape


Date: June 14, 2017 (90 minutes)

Featured Speakers:

  • Steven Whittaker, Executive Director, Avoca Quality Consortium, Senior Consultant, The Avoca Group
  • Ellen Kelso, Senior Consultant, The Avoca Group
  • Kristin Mauri, Global Head Risk Based Monitoring, Bioclinica


ICH E6 R2 may be relatively new, but the team at The Avoca Quality Consortium (AQC) has been working on many of the components of this set of regulatory changes for over five years.

In this practical, guidance-filled webinar, you will learn:

  • An overview of ICH E6 R2
  • Key insights from an extensive review of the ICH E6 R2 guidelines and how these changes will impact areas including risk-based monitoring, risk-based oversight, risk-based quality management, and risk-based inspection preparedness
  • Headlines from AQC research findings that highlight the existing gaps in the industry's ability to manage risks
  • A road map of tools available to navigate the road to ICH E6 R2 compliance
  • The increasing role of technology in supporting ICH E6 R2

So, if you are looking for a webinar that will map the road to compliance on ICH E6 R2, register today!



Steven Whittaker, Executive Director, Avoca Quality Consortium, Senior Consultant, The Avoca Group

Steven Whittaker has significant expertise in pharmaceutical development, clinical development, project management, outsourcing strategies and execution plans. He currently serves as Executive Director for the Avoca Quality Consortium. Whittaker has moderated numerous Clinical Research forums, developing strategic agendas and facilitating the exchange of leadership concepts between clinical development executives across several top-tier pharmaceutical and biotech organizations.

Whittaker retired from Eli Lilly and Company in December 2009, where he served as COO/Sr. Director of Operations and Project Management for the Cardiovascular/Acute Care Platform. He was accountable for leadership and delivery of all global Phase III and IV Cardiovascular/Acute Care development portfolio projects. In addition to other managerial roles with Lilly, Whittaker also led Lilly's Project Management Center of Excellence, establishing standards for leaders of project development.

Ellen Kelso, Senior Consultant, The Avoca Group

Ellen Kelso is an experienced consultant who advises companies on the development of strategic and operational frameworks for regulatory affairs, applied ethics (aka Good Clinical Practices("GCP")) and knowledge management. As a Senior Consultant for The Avoca Group, Ellen led the review and update of the AQC tools, templates, and guidelines in place to ensure ICH E6 R2 requirements are addressed throughout the document library. Ellen has more than 35 years of experience in the pharmaceutical industry serving clinical operations, domestic and international regulatory affairs, and human subject protections. Her experience includes managing worldwide regulatory strategies; providing GCP education and training; and establishing electronic performance, quality, submission, and knowledge management systems. She has held senior positions in a top 5 pharmaceutical company, a global CRO and an IRB.

Kristin Mauri, Global Head Risk Based Monitoring, Bioclinica

Kristin Mauri, MBA, PMP, heads Bioclinica's global risk-based monitoring (RBM) practice and maintains responsibility for the technology and services practices. Ms. Mauri brings to Bioclinica more than 20 years of clinical operations experience and eClinical technology implementation for pharma, biotech and CRO organizations. Prior to joining Bioclinica, Ms. Mauri was Director, Product Strategy at Oracle Health Sciences where she was responsible for growing both the technology partnership program, as well as leading the risk-based monitoring strategy. A recognized thought leader and industry speaker, Ms. Mauri has presented broadly on clinical operations topics within the realm of emerging eClinical technology. Ms. Mauri's educational credentials include an MBA from Lake Forrest Graduate School of Management, MGH Boston master's program coursework in Clinical Investigations, and a bachelor's degree from Pennsylvania State University.


Professionals from Pharma, Biotech, and Clinical Service Providers involved in:

  • Clinical Research
  • Clinical Operations
  • Clinical Quality Assurance
  • Regulatory Compliance
  • Risk Management


The Avoca Group is a driving force behind the continuous improvement of outsourced clinical research. As a developer of progressive solutions to challenges faced in clinical research, Avoca makes a tangible difference to the operations of pharmaceutical companies and clinical service providers.

Contact us at (609) 252-9020 or info@theavocagroup.com

Share this webinar with your colleagues!

Copyright 2016-2017 Honeycomb Worldwide Inc.